Figure 5.
Figure 5. Skewed distribution of the NPS in patients with CMV reactivation (any DNAemia). (A) The skewed distribution of the NPS (IL-2−IFN-γ+TNF-α−ΜIP-1β+ cells within the CMV(pp65)-specific CD8+ T-cell compartment) in patients with CMV reactivation, with the highest levels among those individuals with clinically significant CMV. P value for comparision between groups using Mann-Whitney U test. EC (n = 13); SC (n = 16); NC (n = 13). (B) The 100-day cumulative incidence of CMV reactivation (any DNAemia) by levels of NPS, using 5.7% as cutoff. Specific cutoff was identified using the most significant P value approach. Number of subjects in log-rank analysis was 9 and 17 for NPS low and high, respectively.

Skewed distribution of the NPS in patients with CMV reactivation (any DNAemia). (A) The skewed distribution of the NPS (IL-2IFN-γ+TNF-αΜIP-1β+ cells within the CMV(pp65)-specific CD8+ T-cell compartment) in patients with CMV reactivation, with the highest levels among those individuals with clinically significant CMV. P value for comparision between groups using Mann-Whitney U test. EC (n = 13); SC (n = 16); NC (n = 13). (B) The 100-day cumulative incidence of CMV reactivation (any DNAemia) by levels of NPS, using 5.7% as cutoff. Specific cutoff was identified using the most significant P value approach. Number of subjects in log-rank analysis was 9 and 17 for NPS low and high, respectively.

Close Modal

or Create an Account

Close Modal
Close Modal